IRIS
GALDIERO, MARIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 574
EU - Europa 284
AS - Asia 108
AF - Africa 10
Totale 976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 557
SE - Svezia 82
CN - Cina 80
IT - Italia 47
DE - Germania 37
NL - Olanda 34
IE - Irlanda 32
FI - Finlandia 31
CA - Canada 13
CI - Costa d'Avorio 10
IR - Iran 9
UA - Ucraina 9
GB - Regno Unito 6
IQ - Iraq 6
IN - India 4
MX - Messico 4
VN - Vietnam 4
FR - Francia 3
ID - Indonesia 3
RO - Romania 2
SG - Singapore 2
RU - Federazione Russa 1
Totale 976
Salva come PNG Salva come JPEG
Città #
Chandler 139
Millbury 41
Amsterdam 34
Princeton 32
Ashburn 27
Nanjing 27
Jacksonville 23
Beijing 19
Wilmington 18
Naples 15
Ann Arbor 13
Napoli 13
Ottawa 13
Boston 11
Ardabil 7
Falls Church 7
Hebei 7
Nanchang 7
Seattle 7
Des Moines 6
Kronberg 6
Shenyang 6
Augusta 4
Dong Ket 4
Mexico 4
Boardman 3
Changsha 3
Indiana 3
New York 3
Redmond 3
Tianjin 3
Wonogiri 3
Bucharest 2
Castelnuovo Rangone 2
Dublin 2
Fiumicino 2
Jiaxing 2
Lanzhou 2
Monmouth Junction 2
Norwalk 2
San Mateo 2
Avellino 1
Falkenstein 1
Genzano Di Lucania 1
Jinhua 1
Kish 1
Kunming 1
Meridian 1
Mumbai 1
Paris 1
Prata Di Principato Ultra 1
Pune 1
Redwood City 1
Rome 1
San Francisco 1
San Giuseppe Vesuviano 1
Shanghai 1
Singapore 1
Tappahannock 1
Trecase 1
Washington 1
Yellow Springs 1
Totale 550
Salva come PNG Salva come JPEG
Nome #
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 56
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 54
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 51
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 48
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 47
The role of vitamin D in male fertility: A focus on the testis 45
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 44
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 38
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 37
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 36
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 35
[Chronic kidney disease: fertility and sexuality] 34
Acromegaly and the cardiovascular system 32
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-monthstudy. 32
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 30
New perspectives in the medical treatment of acromegaly 29
Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. 29
Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study 28
Circulating endothelial progenitor cells in acromegaly. 27
Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly. 25
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 24
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 24
Growth hormone, prolactin, and sexuality. 24
The role of dopamine pathway on human sperm: in vitro effect of dopamine receptor agonists and antagonists on sperm motility, kinetics and viability 24
Effect of Cabergoline on Metabolism in Prolactinomas. 23
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 21
Medical consequences of acromegaly: what are the effects of biochemical control? 21
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 19
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy 19
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance 19
Erectile dysfunction is common ammong men with acromegaly and is associated with morbidities related to the disease 16
Treatment with GH receptor antagonist in acromegaly:effect on cardiac arrhythmias. 14
Cushing, acromegaly, GH deficiency and tendons 14
Totale 1.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/202094 45 1 2 0 3 1 0 0 0 4 20 18
2020/2021102 2 2 19 2 3 20 2 2 8 7 27 8
2021/2022242 6 0 0 3 7 35 3 8 39 9 56 76
2022/2023282 36 31 14 25 34 29 1 20 44 37 9 2
2023/2024132 11 29 28 13 10 12 2 24 3 0 0 0
Totale 1.019